📰 Mark Crossley News
Page 2 - Mark Crossley News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mark Crossley. Real-time updates on events, politics, business and more.
January 17, 2024
The chief executive of Indivior, the FTSE 250 addiction specialist, flew into London last week for a brief visit, including to catch up with employees at the group’s UK office in Slough.Staff at the
November 17, 2023
Indivior PLC on Friday announced a new share buyback programme, as it hailed its outlook for medium-term profitable growth. The Chesterfield, Virginia-headquartered pharmaceutical maker said the...
November 10, 2023
Nova Cannabis Inc. Reports Record Q3 2023 Revenue, Achieving Gross Margin Growth Nova Cannabis Inc. (TSX: NOVC) (OTCQB: NVACF) released its unaudited condensed interim consolidated financial statements for the three and nine months ended September 30, 2023. 
November 9, 2023
SLOUGH, United Kingdom and RICHMOND, Va., Nov. 9, 2023 /PRNewswire/ -- Indivior PLC today announced its financial results for the period ending September 30, 2023. The earnings release, investor...
November 9, 2023
Drugmaker Indivior Plc clinched a US contract worth up to $111 million for its opioid antidote—part of the government’s preparation for a potential bioterrorism attack with drugs such as fentanyl that can be released into the air. The contract will secure US supplies of Opvee, an opioid reversal medication that…
November 8, 2023
This week’s Deep Dive feature focuses on expanded jobs and career opportunities coming to Raleigh as Indivior, a biotech company, expands a North Raleigh facility previously operated by Sagent.
November 3, 2023
A Virginia-based pharmaceutical company plans to invest more than $60 million and add 35 jobs at a North Raleigh facility.
October 23, 2023
Indivior concludes multi-district antitrust litigation
October 23, 2023
Among the companies with reports and trading updates today are Vistry, Keller and Upland Resources.
October 23, 2023
Indivior PLC on Monday said it has reached an agreement to settle a US multi-district Suboxone litigation case, forking out USD385 million in the process. Indivior shares rose 6.5% to 1,607.42 pence...